InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
3.120
-0.270 (-7.96%)
At close: Feb 21, 2025, 4:00 PM
3.190
+0.070 (2.24%)
After-hours: Feb 21, 2025, 7:31 PM EST
InMed Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
| Net Income | -7.91 | -7.68 | -7.95 | -18.6 | -10.2 | -8.94 | |
| Depreciation & Amortization | 0.58 | 0.6 | 0.6 | 0.51 | 0.23 | 0.18 | |
| Loss (Gain) From Sale of Assets | - | - | - | 0.01 | 0 | 0 | |
| Asset Writedown & Restructuring Costs | - | - | - | 3.47 | - | - | |
| Stock-Based Compensation | 0.15 | 0.14 | 0.28 | 0.78 | 0.61 | 0.99 | |
| Provision & Write-off of Bad Debts | - | - | 0.05 | - | - | - | |
| Other Operating Activities | 0.07 | 0.32 | 0.31 | 1.32 | 0.02 | 0.03 | |
| Change in Accounts Receivable | 0.11 | -0.09 | -0.22 | -0.04 | 0.04 | 0.02 | |
| Change in Inventory | -0.4 | 0.07 | 0.57 | -2 | - | - | |
| Change in Accounts Payable | 0.08 | 0.05 | -0.81 | -0.81 | 0.35 | 0.47 | |
| Change in Other Net Operating Assets | 0.03 | -0.39 | -0.11 | -0.22 | -0.84 | -0.13 | |
| Operating Cash Flow | -7.29 | -6.99 | -7.28 | -15.58 | -9.79 | -7.37 | |
| Capital Expenditures | -0 | -0.01 | -0.16 | -0.04 | -0 | -0.04 | |
| Sale of Property, Plant & Equipment | - | - | - | - | - | 0 | |
| Cash Acquisitions | - | - | -0.5 | -0.21 | - | - | |
| Investment in Securities | - | - | - | - | - | 3.83 | |
| Investing Cash Flow | -0 | -0.01 | -0.66 | -0.67 | -0 | 3.79 | |
| Short-Term Debt Repaid | - | - | - | -0.29 | - | - | |
| Total Debt Repaid | - | - | - | -0.29 | - | - | |
| Net Debt Issued (Repaid) | - | - | - | -0.29 | - | - | |
| Issuance of Common Stock | 0.86 | 4.65 | 10.68 | 17.15 | 12.47 | - | |
| Other Financing Activities | 0.31 | - | - | -1.78 | -1.62 | -0.03 | |
| Financing Cash Flow | 1.18 | 4.65 | 10.68 | 15.07 | 10.85 | -0.03 | |
| Foreign Exchange Rate Adjustments | - | - | - | - | 0.49 | -0.42 | |
| Net Cash Flow | -6.12 | -2.34 | 2.74 | -1.19 | 1.56 | -4.03 | |
| Free Cash Flow | -7.29 | -7 | -7.45 | -15.62 | -9.79 | -7.42 | |
| Free Cash Flow Margin | -150.92% | -152.14% | -180.02% | -1434.03% | - | - | |
| Free Cash Flow Per Share | -12.79 | -18.36 | -60.81 | -557.14 | -728.60 | -710.40 | |
| Levered Free Cash Flow | -4.06 | -4.02 | -4.81 | -8.87 | -5.35 | -4.17 | |
| Unlevered Free Cash Flow | -3.85 | -4.02 | -4.81 | -8.87 | -5.35 | -4.17 | |
| Change in Net Working Capital | -0.28 | -0.33 | 0.29 | 1.63 | -0.02 | -0.41 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.